Biotechnology
Compare Stocks
5 / 10Stock Comparison
CDT vs CSWC vs TPVG vs ARCC vs GBDC
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Asset Management
CDT vs CSWC vs TPVG vs ARCC vs GBDC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Biotechnology | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $368K | $1.43B | $243M | $13.61B | $3.43B |
| Revenue (TTM) | $696M | $164M | $97M | $3.15B | $871M |
| Net Income (TTM) | $17M | $103M | $-12M | $1.15B | $205M |
| Gross Margin | 36.9% | 66.5% | 83.5% | 75.7% | 81.5% |
| Operating Margin | 6.4% | 48.5% | 77.9% | 69.7% | 78.9% |
| Forward P/E | 0.0x | 10.1x | 6.5x | 9.9x | 9.2x |
| Total Debt | $1.29B | $956M | $469M | $15.99B | $4.90B |
| Cash & Equiv. | $390M | $43M | $20M | $924M | $24M |
CDT vs CSWC vs TPVG vs ARCC vs GBDC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| CDT Equity Inc. (CDT) | 100 | 0.0 | -100.0% |
| Capital Southwest C… (CSWC) | 100 | 101.1 | +1.1% |
| TriplePoint Venture… (TPVG) | 100 | 34.3 | -65.7% |
| Ares Capital Corpor… (ARCC) | 100 | 90.5 | -9.5% |
| Golub Capital BDC, … (GBDC) | 100 | 86.5 | -13.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDT vs CSWC vs TPVG vs ARCC vs GBDC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CDT has the current edge in this matchup, primarily because of its strength in growth and value.
- 8.9% revenue growth vs CSWC's 7.7%
- Lower P/E (0.0x vs 9.9x)
CSWC is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 234.2% 10Y total return vs ARCC's 139.2%
- +34.0% vs CDT's -99.8%
- 4.8% ROA vs TPVG's -1.5%, ROIC 3.5% vs 7.2%
TPVG ranks third and is worth considering specifically for income & stability and bank quality.
- Dividend streak 0 yrs, beta 0.83, yield 17.1%
- NIM 7.4% vs ARCC's 3.6%
- 50.6% margin vs CDT's 2.4%
- 17.1% yield, vs CSWC's 10.2%, (1 stock pays no dividend)
Among these 5 stocks, ARCC doesn't own a clear edge in any measured category.
GBDC is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 42.5%, EPS growth 4.4%
- Lower volatility, beta 0.64, current ratio 5.35x
- PEG 0.30 vs TPVG's 6.41
- Beta 0.64, yield 10.5%, current ratio 5.35x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.9% revenue growth vs CSWC's 7.7% | |
| Value | Lower P/E (0.0x vs 9.9x) | |
| Quality / Margins | 50.6% margin vs CDT's 2.4% | |
| Stability / Safety | Beta 0.64 vs CDT's 1.84 | |
| Dividends | 17.1% yield, vs CSWC's 10.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +34.0% vs CDT's -99.8% | |
| Efficiency (ROA) | 4.8% ROA vs TPVG's -1.5%, ROIC 3.5% vs 7.2% |
CDT vs CSWC vs TPVG vs ARCC vs GBDC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
CDT vs CSWC vs TPVG vs ARCC vs GBDC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CDT leads in 2 of 6 categories
TPVG leads 1 • CSWC leads 1 • ARCC leads 0 • GBDC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TPVG leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARCC is the larger business by revenue, generating $3.1B annually — 32.4x TPVG's $97M. TPVG is the more profitable business, keeping 50.6% of every revenue dollar as net income compared to CDT's 2.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $696M | $164M | $97M | $3.1B | $871M |
| EBITDAEarnings before interest/tax | $47M | $142M | -$22M | $2.0B | $431M |
| Net IncomeAfter-tax profit | $17M | $103M | -$12M | $1.1B | $205M |
| Free Cash FlowCash after capex | -$6M | -$69M | $35M | $1.1B | $313M |
| Gross MarginGross profit ÷ Revenue | +36.9% | +66.5% | +83.5% | +75.7% | +81.5% |
| Operating MarginEBIT ÷ Revenue | +6.4% | +48.5% | +77.9% | +69.7% | +78.9% |
| Net MarginNet income ÷ Revenue | +2.4% | +43.1% | +50.6% | +41.3% | +43.2% |
| FCF MarginFCF ÷ Revenue | -0.9% | -132.6% | -58.7% | +36.3% | -13.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +100.4% | +113.3% | -2.3% | -63.9% | -160.0% |
Valuation Metrics
CDT leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 0.0x trailing earnings, CDT trades at a 100% valuation discount to CSWC's 16.3x P/E. Adjusting for growth (PEG ratio), GBDC offers better value at 0.30x vs TPVG's 4.84x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $367,825 | $1.4B | $243M | $13.6B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $896M | $2.3B | $691M | $28.7B | $8.3B |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | 16.32x | 4.91x | 10.19x | 9.26x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.06x | 6.50x | 9.92x | 9.15x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 4.84x | 0.99x | 0.30x |
| EV / EBITDAEnterprise value multiple | 2.43x | 27.43x | 9.13x | 13.09x | 12.08x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 8.71x | 2.50x | 4.33x | 3.93x |
| Price / BookPrice ÷ Book value/share | 0.00x | 1.39x | 0.68x | 0.93x | 0.88x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 11.92x | — |
Profitability & Efficiency
CDT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CSWC delivers a 10.3% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-3 for TPVG. CDT carries lower financial leverage with a 1.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to TPVG's 1.33x. On the Piotroski fundamental quality scale (0–9), CDT scores 6/9 vs CSWC's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.6% | +10.3% | -3.4% | +8.1% | +5.2% |
| ROA (TTM)Return on assets | +1.0% | +4.8% | -1.5% | +3.8% | +2.3% |
| ROICReturn on invested capital | +21.9% | +3.5% | +7.2% | +5.7% | +5.9% |
| ROCEReturn on capital employed | +22.2% | +4.6% | +9.4% | +7.5% | +7.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 1 | 5 | 4 | 4 |
| Debt / EquityFinancial leverage | 1.02x | 1.08x | 1.33x | 1.12x | 1.23x |
| Net DebtTotal debt minus cash | $896M | $913M | $449M | $15.1B | $4.9B |
| Cash & Equiv.Liquid assets | $390M | $43M | $20M | $924M | $24M |
| Total DebtShort + long-term debt | $1.3B | $956M | $469M | $16.0B | $4.9B |
| Interest CoverageEBIT ÷ Interest expense | -1.05x | 2.91x | -1.02x | 2.98x | 1.62x |
Total Returns (Dividends Reinvested)
CSWC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSWC five years ago would be worth $15,138 today (with dividends reinvested), compared to $0 for CDT. Over the past 12 months, CSWC leads with a +34.0% total return vs CDT's -99.8%. The 3-year compound annual growth rate (CAGR) favors CSWC at 20.7% vs CDT's -97.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -94.2% | +11.4% | -6.3% | -4.9% | -0.7% |
| 1-Year ReturnPast 12 months | -99.8% | +34.0% | +19.3% | +0.4% | +3.3% |
| 3-Year ReturnCumulative with dividends | -100.0% | +75.8% | -3.4% | +34.2% | +35.3% |
| 5-Year ReturnCumulative with dividends | -100.0% | +51.4% | -13.5% | +47.0% | +33.2% |
| 10-Year ReturnCumulative with dividends | -100.0% | +234.2% | +93.3% | +139.2% | +61.0% |
| CAGR (3Y)Annualised 3-year return | -97.4% | +20.7% | -1.2% | +10.3% | +10.6% |
Risk & Volatility
Evenly matched — CSWC and GBDC each lead in 1 of 2 comparable metrics.
Risk & Volatility
GBDC is the less volatile stock with a 0.64 beta — it tends to amplify market swings less than CDT's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSWC currently trades 98.2% from its 52-week high vs CDT's 0.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.84x | 0.84x | 0.83x | 0.77x | 0.64x |
| 52-Week HighHighest price in past year | $1425.00 | $24.43 | $7.53 | $23.42 | $15.63 |
| 52-Week LowLowest price in past year | $1.20 | $19.37 | $4.48 | $17.40 | $11.77 |
| % of 52W HighCurrent price vs 52-week peak | +0.1% | +98.2% | +79.5% | +81.0% | +84.1% |
| RSI (14)Momentum oscillator 0–100 | 27.2 | 63.7 | 58.3 | 56.7 | 52.8 |
| Avg Volume (50D)Average daily shares traded | 126K | 664K | 504K | 7.5M | 2.4M |
Analyst Outlook
Evenly matched — CSWC and TPVG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CSWC as "Buy", TPVG as "Hold", ARCC as "Buy", GBDC as "Buy". Consensus price targets imply 49.4% upside for TPVG (target: $9) vs -6.2% for CSWC (target: $23). For income investors, TPVG offers the higher dividend yield at 17.11% vs ARCC's 2.02%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $22.50 | $8.95 | $21.88 | $14.33 |
| # AnalystsCovering analysts | — | 10 | 12 | 32 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | +10.2% | +17.1% | +2.0% | +10.5% |
| Dividend StreakConsecutive years of raises | 1 | 3 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $2.45 | $1.02 | $0.38 | $1.38 |
| Buyback YieldShare repurchases ÷ mkt cap | +28.8% | 0.0% | 0.0% | 0.0% | +2.3% |
CDT leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). TPVG leads in 1 (Income & Cash Flow). 2 tied.
CDT vs CSWC vs TPVG vs ARCC vs GBDC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CDT or CSWC or TPVG or ARCC or GBDC a better buy right now?
For growth investors, Golub Capital BDC, Inc.
(GBDC) is the stronger pick with 42. 5% revenue growth year-over-year, versus 7. 7% for Capital Southwest Corporation (CSWC). CDT Equity Inc. (CDT) offers the better valuation at 0. 0x trailing P/E, making it the more compelling value choice. Analysts rate Capital Southwest Corporation (CSWC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CDT or CSWC or TPVG or ARCC or GBDC?
On trailing P/E, CDT Equity Inc.
(CDT) is the cheapest at 0. 0x versus Capital Southwest Corporation at 16. 3x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Golub Capital BDC, Inc. wins at 0. 30x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CDT or CSWC or TPVG or ARCC or GBDC?
Over the past 5 years, Capital Southwest Corporation (CSWC) delivered a total return of +51.
4%, compared to -100. 0% for CDT Equity Inc. (CDT). Over 10 years, the gap is even starker: CSWC returned +234. 2% versus CDT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CDT or CSWC or TPVG or ARCC or GBDC?
By beta (market sensitivity over 5 years), Golub Capital BDC, Inc.
(GBDC) is the lower-risk stock at 0. 64β versus CDT Equity Inc. 's 1. 84β — meaning CDT is approximately 187% more volatile than GBDC relative to the S&P 500. On balance sheet safety, CDT Equity Inc. (CDT) carries a lower debt/equity ratio of 102% versus 133% for TriplePoint Venture Growth BDC Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — CDT or CSWC or TPVG or ARCC or GBDC?
By revenue growth (latest reported year), Golub Capital BDC, Inc.
(GBDC) is pulling ahead at 42. 5% versus 7. 7% for Capital Southwest Corporation (CSWC). On earnings-per-share growth, the picture is similar: CDT Equity Inc. grew EPS 128. 8% year-over-year, compared to -28. 3% for Capital Southwest Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CDT or CSWC or TPVG or ARCC or GBDC?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus 8. 7% for CDT Equity Inc. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GBDC leads at 78. 9% versus 11. 6% for CDT. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CDT or CSWC or TPVG or ARCC or GBDC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Golub Capital BDC, Inc. (GBDC) is the more undervalued stock at a PEG of 0. 30x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 5x forward P/E versus 10. 1x for Capital Southwest Corporation — 3. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 49. 4% to $8. 95.
08Which pays a better dividend — CDT or CSWC or TPVG or ARCC or GBDC?
In this comparison, TPVG (17.
1% yield), GBDC (10. 5% yield), CSWC (10. 2% yield), ARCC (2. 0% yield) pay a dividend. CDT does not pay a meaningful dividend and should not be held primarily for income.
09Is CDT or CSWC or TPVG or ARCC or GBDC better for a retirement portfolio?
For long-horizon retirement investors, Golub Capital BDC, Inc.
(GBDC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 64), 10. 5% yield). CDT Equity Inc. (CDT) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GBDC: +61. 0%, CDT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CDT and CSWC and TPVG and ARCC and GBDC?
These companies operate in different sectors (CDT (Healthcare) and CSWC (Financial Services) and TPVG (Financial Services) and ARCC (Financial Services) and GBDC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CDT is a small-cap deep-value stock; CSWC is a small-cap deep-value stock; TPVG is a small-cap high-growth stock; ARCC is a mid-cap high-growth stock; GBDC is a small-cap high-growth stock. CSWC, TPVG, ARCC, GBDC pay a dividend while CDT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.